Ranking Year:
# | Company Name | Region | Tech Topics | Total |
---|
1 | ![]() | Health care,Mitral valve surgery,Health equity, ...[+2] | Literature: 18 | |
2 | ![]() | Medical school,Clinical research,Health care, ...[+2] | Literature: 11 | |
3 | ![]() | Immune system,Health care,Biomedicine, ...[+2] | Literature: 8 | |
4 | ![]() | OH, US | Health care,Face transplant,Coronary artery bypass surgery, ...[+2] | Literature: 7 |
5 | ![]() | Monoclonal antibody,Clinical trial,Cholesterol, ...[+2] | Literature: 6 | |
6 | ![]() | Medicine,Biotechnology,Donation, ...[+1] | Literature: 5 | |
7 | ![]() | Science education,Medical equipment,Health care, ...[+2] | Literature: 5 | |
8 | ![]() | Health care,Clinical trial,Drug, ...[+2] | Literature: 4 | |
9 | Vascular Medicine,Health care,Lipid management, ...[+2] | Literature: 4 | ||
10 | Drug marketing,Breast cancer,Health care, ...[+2] | Literature: 4 | ||
11 | ![]() | Biotechnology,Biology,Medicine, ...[+2] | Literature: 3 | |
12 | ![]() | Health care,National security,Health Insurance Portability and Accountability Act, ...[+2] | Literature: 3 | |
13 | ![]() | Health care,Hospitality industry,Continuing care, ...[+2] | Literature: 3 | |
14 | ![]() | Medicine,Health care,Humalog Mix, ...[+2] | Literature: 2 | |
15 | ![]() | Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2] | Literature: 2 | |
16 | ![]() | Asset management,Market research,Gene delivery, ...[+2] | Literature: 2 | |
17 | ![]() | Surgery,Knee replacement,Health care, ...[+2] | Literature: 2 | |
18 | ![]() | Public opinion,Health care,Chemistry, ...[+2] | Literature: 2 | |
19 | ![]() | MI, US | Group practices,Health care,Hospitality industry | Literature: 2 |
20 | ![]() | Germline,Xenotransplantation,Cytogenetics, ...[+2] | Literature: 2 |